IL1R2 may provide an insight into the biology of recurrent ovarian tumors, suggesting an initial immune response to the relapsing neoplasm and may secondly represent a surrogate marker of recurrence in ovarian cancer. This evidence concerns the gene IL1R2 and ovarian cancer.